Team:Duke/Team

TEAM

PROJECT

PARTS

Human Practices

AWARDS

Education & Engagement

JUDGING FORM ⇗

Our Team

	Daniel Getman Daniel Getman is a senior at Duke University studying Neuroscience. He joined the Duke iGEM team and Lynch Lab in fall 2017. His hobbies include archery, hiking, and spending time with friends. After graduating he plans to taking a gap year to continue his research on miraculin and afterwards attend medical school.
Maria Ter Weele Maria is a junior majoring Biomedical Engineering at Duke. She is passionate about statistics and is constantly searching to learn new things about biology. Originally from Virginia, Maria enjoys walks in the woods with her dogs, hot chocolate, and reading.
	Adam Yaseen Adam write something pls
Keng Zhang Keng write something pls
	Joe Choo-Choy Joe write something pls
Trudy Zou Trudy write something pls

Our Advisors

	Michael Lynch Michael Lynch MD, PhD is an assistant professor of both Chemistry and Biomedical Engineering at Duke University. He received both his Ph.D and M.D. at the University of Colorado at Boulder. His research focuses on modifying bacterial pathways to produce chemicals essential for applications such as pharmacology and industry.
Adim Moreb Adim is a Ph.D. student in the Biomedical Engineering department. He joined the Lynch lab in 2015. His work focuses on improving the speed and efficiency of genome engineering in bacteria.
	John Decker John is a Ph.D. student in the Department of Biomedical Engineering. Originally from middle Tennessee, he completed his undergraduate studies at the University of Alabama at Birmingham, where he earned a B.S. in Neuroscience and conducted research on eye movements and stereoscopic vision in humans. Outside of school and the lab, John enjoys the outdoors, literature, and fencing, and also holds a private pilot's license.
Romel Menacho- Melgar Romel is a Biomedical Engineering PhD student. Originally from Peru, he came to the US to the University of South Carolina to earn a BS degree in Biomedical Engineering in 2009. He started his graduate studies at Duke in 2013 and joined the Lynch Lab in 2015. His project involves developing a platform for in vivo peptide lipidation for novel materials and pharmaceuticals